Connor Clark & Lunn Investment Management Ltd. Purchases New Position in Select Medical Holdings Co. (NYSE:SEM)

Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Select Medical Holdings Co. (NYSE:SEM) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 37,848 shares of the health services provider’s stock, valued at approximately $1,320,000.

Other institutional investors also recently made changes to their positions in the company. Hexagon Capital Partners LLC lifted its holdings in Select Medical by 528.7% during the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after purchasing an additional 645 shares during the last quarter. Transcendent Capital Group LLC acquired a new stake in shares of Select Medical during the second quarter worth $35,000. Canada Pension Plan Investment Board bought a new stake in shares of Select Medical in the second quarter valued at about $39,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Select Medical in the second quarter valued at about $60,000. Finally, GAMMA Investing LLC increased its position in Select Medical by 52.8% during the second quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock worth $70,000 after acquiring an additional 685 shares during the period. Institutional investors own 89.48% of the company’s stock.

Analysts Set New Price Targets

SEM has been the subject of a number of recent research reports. Royal Bank of Canada boosted their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Bank of America started coverage on Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target on the stock. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday. Finally, StockNews.com lowered Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $40.75.

Select Medical Stock Performance

Shares of NYSE:SEM opened at $21.32 on Wednesday. The company’s 50 day simple moving average is $35.26 and its 200 day simple moving average is $35.09. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical Holdings Co. has a 1 year low of $20.17 and a 1 year high of $40.98. The stock has a market capitalization of $2.76 billion, a price-to-earnings ratio of 9.96, a price-to-earnings-growth ratio of 1.78 and a beta of 1.42.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. Select Medical’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.46 EPS. As a group, research analysts predict that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s payout ratio is 23.36%.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.